Leap Therapeutics Stock Volume Indicators Chaikin AD Oscillator
| LPTX Stock | USD 2.95 0.03 1.03% |
| Symbol |
The output start index for this execution was nine with a total number of output elements of fifty-two. The Accumulation/Distribution Oscillator was developed by Marc Chaikin. It is a moving average oscillator based on the Accumulation/Distribution indicator. The Chaikin Oscillator is created by subtracting Leap Therapeutics 10-period exponential moving average of the Accumulation/Distribution Line from a 3-period exponential moving average of the Accumulation/Distribution Line.
Leap Therapeutics Technical Analysis Modules
Most technical analysis of Leap Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Leap from various momentum indicators to cycle indicators. When you analyze Leap charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Leap Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Leap Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Leap Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Leap Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Leap Therapeutics's daily price indicators and compare them against related drivers, such as volume indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Leap Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Leap Therapeutics, we also check how macroeconomic factors affect Leap Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2010 | 2023 | 2024 (projected) | Dividend Yield | 0.0142 | 0.00261 | 0.00248 | Price To Sales Ratio | 88.99 | 166.84 | 109.75 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Leap Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Leap Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Leap Therapeutics' short interest history, or implied volatility extrapolated from Leap Therapeutics options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Cash Cows Invested few shares | |
 | SRI Sustainable Growth Invested few shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Investor Favorites Invested over 60 shares | |
 | Macroaxis Index Invested few shares | |
 | Momentum Invested few shares | |
 | FinTech Invested over 40 shares | |
 | Social Domain Invested few shares |
Additional Tools for Leap Stock Analysis
When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.